Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001821586-24-000029
Filing Date
2024-11-07
Accepted
2024-11-07 07:05:39
Documents
83
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mnlk-20240930.htm   iXBRL 10-Q 1222966
2 EX-31.1 mltx_2024q3xex311dasilva.htm EX-31.1 10306
3 EX-31.2 mltx_2024q3xex312bodenstedt.htm EX-31.2 10218
4 EX-32.1 mltx_2024q3xex321dasilva.htm EX-32.1 4955
5 EX-32.2 mltx_2024q3xex322bodenstedt.htm EX-32.2 4892
  Complete submission text file 0001821586-24-000029.txt   6950144

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mnlk-20240930.xsd EX-101.SCH 45641
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mnlk-20240930_cal.xml EX-101.CAL 71218
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mnlk-20240930_def.xml EX-101.DEF 278248
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mnlk-20240930_lab.xml EX-101.LAB 583442
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mnlk-20240930_pre.xml EX-101.PRE 454728
86 EXTRACTED XBRL INSTANCE DOCUMENT mnlk-20240930_htm.xml XML 867388
Mailing Address DORFSTRASSE 29 ZUG V8 6300
Business Address DORFSTRASSE 29 ZUG V8 6300 41 41 510 8022
MoonLake Immunotherapeutics (Filer) CIK: 0001821586 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39630 | Film No.: 241433101
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)